Publications

314.
Marrocco I., Romaniello D., Vaknin I. et al. (2021) EMBO Molecular Medicine. 13144.  Abstract [All authors]
313.
Su C., Zhang J., Yarden Y. & Fu L. (2021) Signal Transduction and Targeted Therapy. 6, 1, 109.  Abstract
312.
Yang C., Yang C., Yarden Y., To K. K. & Fu L. (2021) Drug Resistance Updates. 54, 100741.  Abstract
311.
Borgoni S., Sofyalı E., Soleimani M. et al. (2020) Cancers. 12, 10, 2918.  Abstract [All authors]
310.
Gaviraghi M., Rabellino A., Andolfo A. et al. (2020) Scientific Reports. 10, 16906.  Abstract [All authors]
309.
Romaniello D., Marrocco I., Nataraj N. B. et al. (2020) Cancers. 12, 9, 2394.  Abstract [All authors]
308.
Hoshino A., Kim H. S., Bojmar L. et al. (2020) Cell. 182, 4, p. 1044-1061  Abstract [All authors]
307.
Wang X., Wang F., Zhong M., Yarden Y. & Fu L. (2020) Molecular Cancer. 19, 1, 81.  Abstract
306.
Mur E. B., Bernardo S., Papon L. et al. (2020) Journal of Clinical Investigation. 130, 2, p. 612-624  Abstract [All authors]
305.
Ghosh S., Marrocco I. & Yarden Y. (2020) Advances in Cancer Research. Fisher P. B. & Kumar R.(eds.). Vol. 147. p. 1-57  Abstract
304.
Srivastava S., Nataraj N. B., Sekar A. et al. (2019) Cell Reports. 29, 1, p. 104-117  Abstract [All authors]
303.
Maron R., Schechter B., Nataraj N. B. et al. (2019) Biochemical and Biophysical Research Communications. 513, 1, p. 219-225  Abstract
[All authors]
302.
Verduci L., Strano S., Yarden Y. & Blandino G. (2019) Molecular Oncology. 13, 4, p. 669-680  Abstract
301.
Kubli S. P., Bassi C., Roux C. et al. (2019) Proceedings of the National Academy of Sciences of the United States of America. 116, 9, p. 3604-3613  Abstract [All authors]
300.
Marrocco I., Romaniello D. & Yarden Y. (2019) Human Monoclonal Antibodies. Steinitz M. S.(eds.). p. 11-51  Abstract
299.
Romaniello D., Mazzeo L., Mancini M. et al. (2018) Clinical Cancer Research. 24, 22, p. 5610-5621  Abstract
[All authors]
298.
Gelfo V., Mazzeschi M., Grilli G. et al. (2018) Cancers. 10, 10, 355.  Abstract [All authors]
297.
Kreitman M., Noronha A. & Yarden Y. (2018) FEBS Letters. 592, 13, p. 2199-2212  Abstract
296.
Arandkar S., Furth N., Elisha Y. et al. (2018) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415  Abstract [All authors]
295.
Claus J., Patel G., Autore F. et al. (2018) eLife. 7, 32271.  Abstract [All authors]
294.
Muti P., Donzelli S., Sacconi A. et al. (2018) Carcinogenesis. 39, 2, p. 98-108  Abstract [All authors]
293.
Mancini M., Gal H., Gaborit N. et al. (2018) EMBO Molecular Medicine. 10, 2, p. 294-308  Abstract [All authors]
292.
Roth L., Srivastava S., Lindzen M. et al. (2018) Science Signaling. 11, 515, 0949.  Abstract [All authors]
291.
Enuka Y., Feldman M. E., Chowdhury A. et al. (2017) Nucleic Acids Research. 45, 22, p. 12681–12699  Abstract [All authors]
290.
Dahlhoff M., Gaborit N., Bultmann S., Leonhardt H., Yarden Y. & Schneider M. R. (2017) FEBS Journal. 284, 19, p. 3339-3349  Abstract
289.
Golan T., Stossel C., Schvimer M. et al. (2017) Oncotarget. 8, 25, p. 40778-40790  Abstract [All authors]
288.
Savidor A., Barzilay R., Elinger D., Yarden Y., Lindzen M., Gabashvili A., Tal O. A. & Levin Y. (2017) Molecular & Cellular Proteomics. 16, 6, p. 1151-1161  Abstract
287.
Tarcic O., Granit R. Z., Pateras I. S. et al. (2017) Cell Death and Differentiation. 24, 4, p. 694-704  Abstract [All authors]
286.
Golan-Lavi R., Giacomelli C., Fuks G. et al. (2017) Cell Reports. 18, 13, p. 3129-3142  Abstract [All authors]
285.
Sas-Chen A., Srivastava S. & Yarden Y. (2017) Biochemical Society Transactions. 45, p. 51-64  Abstract
284.
Gelfo V., Rodia M. T., Pucci M. et al. (2016) Oncotarget. 7, 44, p. 72167-72183  Abstract [All authors]
283.
Dittrich C., Kosty M., Jezdic S. et al. (2016) ESMO Open. 1, 5, UNSP e0000.  Abstract [All authors]
282.
Bublil E. M., Cohen T., Arnusch C. J., Peleg A., Pines G., Lavi S. & Yarden Y. (2016) Biochemistry. 55, 39, p. 5520-5530  Abstract
281.
Beyar-Katz O., Magidey K., Ben-Tsedek N. et al. (2016) Journal of Pathology. 239, 3, p. 262-273  Abstract [All authors]
280.
Schneider M. R. & Yarden Y. (2016) Oncogene. 35, 23, p. 2949-2960  Abstract
279.
Grossman M., Ben Chetrit C. N., Zhuravlev A., Afik R., Bassat E., Solomonov I., Yarden Y. & Sagi I. (2016) Cancer Res.. 93, 5, 052206 .  Abstract
278.
Carvalho S., Levi-Schaffer F., Sela M. & Yarden Y. (2016) British Journal of Pharmacology. 173, 9, p. 1407-24 26833433.  Abstract
277.
Enuka Y., Lauriola M., Sas-Chen A., Ulitsky I. & Yarden Y. (2016) Nucleic Acids Research. 44, 3, p. 1370-1383  Abstract
276.
Donzelli S., Cioce M., Muti P., Strano S., Yarden Y. & Blandino G. (2016) Seminars in Cell & Developmental Biology. 50, p. 133-142  Abstract
275.
274.
Mancini M. & Yarden Y. (2016) Seminars in Cell & Developmental Biology. 50, p. 164-176  Abstract
273.
Carvalho S., Lindzen M., Lauriola M. et al. (2016) Oncogene. 35, 4, p. 438 47.  Abstract
[All authors]
272.
Toth G., Szoor A., Simon L., Yarden Y., Szollosi J. & Vereb G. (2016) mAbs. 8, 7, p. 1361-1370  Abstract
271.
Sas-Chen A., Aure M. R., Leibovich L. et al. (2016) EMBO Molecular Medicine. 8, 9, p. 1052-64  Abstract
[All authors]
270.
Gaborit N., Lindzen M. & Yarden Y. (2016) Human Vaccines & Immunotherapeutics. 12, 3, p. 576-592  Abstract
269.
Wilson S., Tod M., Ouerdani A. et al. (2015) CPT: Pharmacometrics and Systems Pharmacology. 4, 12, p. 720-727  Abstract
[All authors]
268.
Donzelli S., Mori F., Bellissimo T. et al. (2015) Oncotarget. 6, 34, p. 35183-35201  Abstract [All authors]
267.
Capparelli C., Rosenbaum S., Berman-Booty L. D. et al. (2015) Cancer Research. 75, p. 3554-3567  Abstract
[All authors]
266.
Rosenbaum S., Capparelli C., Berman-Booty L., Gaborit N., Zhan T., Davies M., Setiady Y., Yarden Y. & Aplin A. (2015) Molecular Cancer Therapeutics. 14, 7,  Abstract
265.
Mancini M., Gaborit N., Lindzen M., Salame T. M., Dall'Ora M., Sevilla-Sharon M., Abdul-Hai A., Downward J. & Yarden Y. (2015) Science Signaling. 8, 379, ra53.  Abstract
264.
D'Uva G., Aharonov A., Lauriola M. et al. (2015) Nature Cell Biology. 17, 5, p. 627-U207  Abstract [All authors]
263.
Cohen-Dvashi H., Ben Chetrit C. N., Russell R. et al. (2015) EMBO Molecular Medicine. 7, 3, p. 299-314  Abstract
[All authors]
262.
Kedmi M., Ben Chetrit C. N., Koerner C. et al. (2015) Science Signaling. 8, 368, ra29.  Abstract [All authors]
261.
Mahlknecht G., Sela M. & Yarden Y. (2015) Gene Therapy of Solid Cancers. p. 3-15  Abstract
260.
Gaborit N., Abdul-Hai A., Mancini M. et al. (2015) Proceedings of the National Academy of Sciences of the United States of America. 112, 3, p. 839-844  Abstract
[All authors]
259.
Yarden Y. & Sela M. (2015) Clinical Cancer Research. 21, 18, p. 4030-4032  Abstract
258.
Ben Chetrit C. N., Chetrit D., Russell R. et al. (2015) Science Signaling. 8, 360, ra7.  Abstract [All authors]
257.
Muti P., Sacconi A., Hossain A. et al. (2014) Cancer Epidemiology Biomarkers & Prevention. 23, 11, p. 2471-2481  Abstract
[All authors]
256.
Lauriola M., Enuka Y., Zeisel A. et al. (2014) Nature Communications. 5,  Abstract [All authors]
255.
Feldman M. & Yarden Y. (2014) FEBS Letters. 588, 15, p. 2407-2414  Abstract
254.
Blandino G., Fazi F., Donzelli S., Kedmi M., Sas-Chen A., Muti P., Strano S. & Yarden Y. (2014) FEBS Letters. 588, 16, p. 2639-2652  Abstract
253.
Kiuchi T., Ortiz-Zapater E., Monypenny J. et al. (2014) Science Signaling. 7, 339, ra78.  Abstract [All authors]
252.
Bartsch R., Frings S., Marty M. et al. (2014) Annals of Oncology. 25, 4, p. 773-780  Abstract
[All authors]
251.
Schneider M. R. & Yarden Y. (2014) Seminars in Cell & Developmental Biology. 28, p. 57-61  Abstract
250.
Burgess A. W., Henis Y. I., Hynes N. E., Jovin T., Levitzki A., Pinkas-Kramarski R. & Yarden Y. (2014) Growth Factors. 32, 2, p. 74-81  Abstract
249.
HER
Kostler W. & Yarden Y. (2014) MOLECULAR ONCOLOGY: CAUSES OF CANCER AND TARGETS FOR TREATMENT. p. 85-109  Abstract
248.
Koestler W. J., Zeisel A., Koerner C. et al. (2013) PLoS ONE. 8, 12,  Abstract
[All authors]
247.
Mellman I. & Yarden Y. (2013) Cold Spring Harbor perspectives in biology. 5, 12,  Abstract
246.
D'Uva G., Bertoni S., Lauriola M. et al. (2013) PLoS ONE. 8, 11,  Abstract
[All authors]
245.
Maron R., Schechter B., Mancini M., Mahlknecht G., Yarden Y. & Sela M. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 38, p. 15389-15394  Abstract
244.
Yarden Y. & Caldes C. (2013) European Journal of Cancer. 49, 12, p. 2619-2620  Abstract
243.
Biagioni F., Ben-Moshe N. B., Fontemaggi G., Yarden Y., Domany E. & Blandino G. (2013) Cell Cycle. 12, 15, p. 2371-2375  Abstract
242.
Mahlknecht G., Maron R., Mancini M., Schechter B., Sela M. & Yarden Y. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 20, p. 8170-8175  Abstract
241.
Zeisel A., Yitzhaky A., Koerner C., Lauriola M., Cohen-Dvashi H., Koestler W. J., Yarden Y., Wiemann S. & Domany E. (2013) Journal of Biomolecular Screening. 18, 3, p. 356-360  Abstract
240.
Barnea I., Haif S., Keshet R. et al. (2013) Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck. 35, 3, p. 399-407  Abstract
[All authors]
239.
Ben Chetrit C. N., Tarcic G. & Yarden Y. (2013) Cell Adhesion & Migration. 7, 1, p. 33-37  Abstract
238.
Ferraro D. A., Gaborit N., Maron R. et al. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 5, p. 1815-1820  Abstract [All authors]
237.
Ben-Moshe N. B., Avraham R., Kedmi M., Zeisel A., Yitzhaky A., Yarden Y. & Domany E. (2012) Nucleic Acids Research. 40, 21, p. 10614-10627  Abstract
236.
Biagioni F., Ben-Moshe N. B., Fontemaggi G. et al. (2012) EMBO Molecular Medicine. 4, 11, p. 1214-1229  Abstract [All authors]
235.
Pareja F., Ferraro D. A., Rubin C. et al. (2012) Oncogene. 31, 43, p. 4599-4608  Abstract [All authors]
234.
Pradeep C., Zeisel A., Koestler W. J. et al. (2012) Oncogene. 31, 31, p. 3569-3583  Abstract [All authors]
233.
Yarden Y. & Pines G. (2012) Nature Reviews Cancer. 12, 8, p. 553-563  Abstract
232.
Lindzen M., Carvalho S., Starr A. et al. (2012) Oncogene. 31, 30, p. 3505-3515  Abstract
[All authors]
231.
Tarcic G., Avraham R., Pines G. et al. (2012) FASEB Journal. 26, 4, p. 1582-1592  Abstract [All authors]
230.
Sas-Chen A., Avraham R. & Yarden Y. (2012) Journal of Mammary Gland Biology and Neoplasia. 17, 1, p. 3-14  Abstract
229.
Zwang Y., Oren M. & Yarden Y. (2012) Cancer Research. 72, 5, p. 1051-1054  Abstract
228.
Pradeep C., Koestler W. J., Lauriola M. et al. (2012) Oncogene. 31, 7, p. 907-917  Abstract [All authors]
227.
Avraham R. & Yarden Y. (2012) Biochemical Society Transactions. 40, p. 26-30  Abstract
226.
Emde A., Mahlknecht G., Maslak K., Ribba B., Sela M., Possinger K. & Yarden Y. (2011) Translational Oncology. 4, 5, p. 293-300  Abstract
225.
Zeisel A., Koestler W. J., Molotski N. et al. (2011) Molecular Systems Biology. 7, 529.  Abstract [All authors]
224.
Witsch E. J., Mahlknecht G., Wakim J., Sertchook R., Bublil E., Yarden Y. & Sela M. (2011) International Immunology. 23, 6, p. 391-403  Abstract
223.
Zwang Y., Sas-Chen A., Drier Y. et al. (2011) Molecular Cell. 42, 4, p. 524-535  Abstract [All authors]
222.
Emde A. M., Pradeep C., Ferraro D. A., Ben Chetrit C. N., Sela M., Ribba B., Kam Z. & Yarden Y. (2011) Oncogene. 30, 14, p. 1631-1642  Abstract
221.
Avraham R. & Yarden Y. (2011) Nature Reviews Molecular Cell Biology. 12, 2, p. 104-117  Abstract
220.
Koestler W. J. & Yarden Y. (2011) Drugs For Her-2-Positive Breast Cancer. p. 1-32 (Milestones in Drug Therapy).  Abstract
219.
Yarden Y. (2011) Oncologist. 16, p. 23-29  Abstract
218.
Bublil E. M., Pines G., Patel G., Fruhwirth G., Ng T. & Yarden Y. (2010) FASEB Journal. 24, 12, p. 4744-4755  Abstract
217.
Yarden Y. (2010) Oncologist. 15, p. 1-7  Abstract
216.
Pines G., Huang P. H., Zwang Y., White F. M. & Yarden Y. (2010) Oncogene. 29, 43, p. 5850-5860  Abstract
215.
Lindzen M., Lavi S., Leitner O. & Yarden Y. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 28, p. 12559-12563  Abstract
214.
Spangler J. B., Neil J. R., Abramovitch S., Yarden Y., White F. M., Lauffenburger D. A. & Wittrup K. D. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 30, p. 13252-13257  Abstract
213.
Tarcic G. & Yarden Y. (2010) Map Kinase Signaling Protocols. Seger R.(eds.). Second Edition ed. p. 125-135 (Methods in Molecular Biology).  Abstract
212.
The HER2 and EGFR alliance in cancer: defects in system control
Yarden Y. (2010) Ejc Supplements. 8, 5, p. 2-3  Abstract
211.
Pines G., Koestler W. J. & Yarden Y. (2010) FEBS Letters. 584, 12, p. 2699-2706  Abstract
210.
Witsch E., Sela M. & Yarden Y. (2010) Physiology. 25, 2, p. 85-101  Abstract
209.
Mills G. B. & Yarden Y. (2010) Cancer Cell. 17, 3, p. 217-218  Abstract
208.
Tarcic G., Boguslavsky S. K., Wakim J. et al. (2009) Current Biology. 19, 21, p. 1788-1798  Abstract [All authors]
207.
Yarden Y. (2009) New Biotechnology. 25, p. S15-S16  Abstract
206.
Mills G. B., Jurisica I., Yarden Y. & Norman J. C. (2009) Journal of Clinical Investigation. 119, 8, p. 2123-2127  Abstract
205.
Mosesson Y., Chetrit D., Schley L. et al. (2009) Developmental Cell. 16, 5, p. 687-698  Abstract
[All authors]
204.
Ben-Kasus T., Schechter B., Lavi S., Yarden Y. & Sela M. (2009) Proceedings of the National Academy of Sciences of the United States of America. 106, 9, p. 3294-3299  Abstract
203.
Mosesson Y., Mills G. B. & Yarden Y. (2009) Nature Reviews Cancer. 9, 2, p. 146-146  Abstract
202.
Mosesson Y., Mills G. B. & Yarden Y. (2008) Nature Reviews Cancer. 8, 11, p. 835-850  Abstract
201.
Yarden Y. (2008) Ejc Supplements. 6, 9, p. 1-1  Abstract
200.
Seger R., Rodeck U. & Yarden Y. (2008) IET Systems Biology. 2, 1, p. 1-4  Abstract
199.
Yarden Y. (2007) Ejc Supplements. 5, 9, p. 18-19  Abstract
198.
Amit I., Wides R. & Yarden Y. (2007) Molecular Systems Biology. 3,  Abstract
197.
Yarden Y. & Shilo B. (2007) Cell. 131, 5,  Abstract
196.
Shtiegman K., Kochupurakkal B. S., Zwang Y. et al. (2007) Oncogene. 26, 49, p. 6968-6978  Abstract
[All authors]
195.
Sundvall M., Peri L., Maatta J. A., Tvorogov D., Paatero I., Savisalo M., Silvennoinen O., Yarden Y. & Elenius K. (2007) Oncogene. 26, 48, p. 6905-6914  Abstract
194.
Yarden Y. & Amit I. (2007) Ejc Supplements. 5, 4, p. 44-44  Abstract
193.
Zwang Y. & Yarden Y. (2007) Ejc Supplements. 5, 5, p. 427-429  Abstract
192.
Katz M., Amit I. & Yarden Y. (2007) Biochimica Et Biophysica Acta-Molecular Cell Research. 1773, 8, p. 1161-1176  Abstract
191.
Spector N. L., Yarden Y., Smith B. et al. (2007) Proceedings of the National Academy of Sciences of the United States of America. 104, 25, p. 10607-10612  Abstract [All authors]
190.
Ben-Kasus T., Schechter B., Sela M. & Yarden Y. (2007) Molecular Oncology. 1, 1, p. 42-54  Abstract
189.
Bublil E. M. & Yarden Y. (2007) Current Opinion in Cell Biology. 19, 2, p. 124-134  Abstract
188.
Amit I., Citri A., Shay T. et al. (2007) Nature Genetics. 39, 4, p. 503-512  Abstract [All authors]
187.
Zwang Y. & Yarden Y. (2006) EMBO Journal. 25, 18, p. 4195-4206  Abstract
186.
Germano S., Barberis D., Santoro M. M., Penengo L., Citri A., Yarden Y. & Gaudino G. (2006) Journal of Biological Chemistry. 281, 31, p. 21710-21719  Abstract
185.
Bacus S., Yarden Y., Xia W. & Spector N. L. (2006) Labmedicine. 37, 8, p. 482-489  Abstract
184.
Oved S., Mosesson Y., Zwang Y. et al. (2006) Journal of Biological Chemistry. 281, 31, p. 21640-21651  Abstract [All authors]
183.
Citri A. & Yarden Y. (2006) Nature Reviews Molecular Cell Biology. 7, 7, p. 505-516  Abstract
182.
Starr A., Greif J., Vexler A. et al. (2006) International Journal of Cancer. 119, 2, p. 269-274  Abstract
[All authors]
181.
Li R., Soosairajah J., Harari D. et al. (2006) FASEB Journal. 20, 8, p. 1218-+  Abstract
[All authors]
180.
Citri A., Harari D., Shohat G. et al. (2006) Journal of Biological Chemistry. 281, 20, p. 14361-14369  Abstract [All authors]
179.
Monoubiquitylation: A recurrent theme in membrane protein transport
Mosesson Y. & Yarden Y. (2006) Israel Medical Association Journal. 8, 4, p. 233-237  Abstract
178.
Zsebik B., Citri A., Isola J., Yarden Y., Szollosi J. & Vereb G. (2006) Immunology Letters. 104, 2-Jan, p. 146-155  Abstract
177.
The International Consortium on Systems Biology of Receptor Tyrosine Kinase Regulatory Networks
Sakaki Y., Kholodenko B., Hatakeyama M., Kitano H., Kolch W., De Meyts M. P., Yarden Y., Westerhoff H. & Wiley H. (2005) Iee Proceedings Systems Biology. 152, 2, p. 53-54  Abstract
176.
Kochupurakkal B., Harari D., Di-Segni A. et al. (2005) Journal of Biological Chemistry. 280, 9, p. 8503-8512  Abstract
[All authors]
175.
Rubin C., Zwang Y., Vaisman N., Ron D. & Yarden Y. (2005) Journal of Biological Chemistry. 280, 10, p. 9735-9744  Abstract
174.
Kario E., Marmor M., Adamsky K., Citri A., Amit I., Amariglio N., Rechavi G. & Yarden Y. (2005) Journal of Biological Chemistry. 280, 8, p. 7038-7048  Abstract
173.
Friedman L., Rinon A., Schechter B., Lyass L., Lavi S., Bacus S., Sela M. & Yarden Y. (2005) Proceedings of the National Academy of Sciences of the United States of America. 102, 6, p. 1915-1920  Abstract
172.
Rubin C., Gur G. & Yarden Y. (2005) Cell Research. 15, 1, p. 66-71  Abstract
171.
Citri A., Gan J., Mosesson Y., Vereb G., Szollosi J. & Yarden Y. (2004) EMBO Reports. 5, 12, p. 1165-1170  Abstract
170.
Bacus S., Spector N., Seger R. & Yarden Y. (2004) Journal of Immunotherapy. 27, 6, p. S57-S58  Abstract
169.
Yarden Y., Baselga J. & Miles D. (2004) Seminars in Oncology. 31, 5, p. 6-13  Abstract
168.
Gur G., Rubin C., Katz M. et al. (2004) EMBO Journal. 23, 16, p. 3270-3281  Abstract [All authors]
167.
Mosesson Y. & Yarden Y. (2004) Seminars in Cancer Biology. 14, 4, p. 262-270  Abstract
166.
Amit I., Yakir L., Katz M. et al. (2004) Genes & Development. 18, 14, p. 1737-1752  Abstract [All authors]
165.
Marmor M., Skaria K. & Yarden Y. (2004) International Journal of Radiation Oncology Biology Physics. 58, 3, p. 903-913  Abstract
164.
Marmor M. & Yarden Y. (2004) Oncogene. 23, 11, p. 2057-2070  Abstract
163.
Gur G. & Yarden Y. (2004) Nature Biotechnology. 22, 2, p. 169-170  Abstract
162.
The Achilles heel of ErbB-2/HER2 - Regulation by the Hsp90 chaperone machine and potential for pharmacological intervention
Citri A., Kochupurakkal B. & Yarden Y. (2004) Cell Cycle. 3, 1, p. 51-60  Abstract
161.
Shelly M., Mosesson Y., Citri A., Lavi S., Zwang Y., Melamed-Book N., Aroeti B. & Yarden Y. (2003) Developmental Cell. 5, 3, p. 475-486  Abstract
160.
Mosesson Y., Shtiegman K., Katz M., Zwang Y., Vereb G., Szollosi J. & Yarden Y. (2003) Journal of Biological Chemistry. 278, 24, p. 21323-21326  Abstract
159.
Penengo L., Rubin C., Yarden Y. & Gaudino G. (2003) Oncogene. 22, 24, p. 3669-3679  Abstract
158.
Citri A., Skaria K. & Yarden Y. (2003) Experimental Cell Research. 284, 1, p. 54-65  Abstract
157.
Bao J., Gur G. & Yarden Y. (2003) Proceedings of the National Academy of Sciences of the United States of America. 100, 5, p. 2438-2443  Abstract
156.
Shtiegman K. & Yarden Y. (2003) Seminars in Cancer Biology. 13, 1, p. 29-40  Abstract
155.
Rubin C., Litvak V., Medvedovsky H., Zwang Y., Lev S. & Yarden Y. (2003) Current Biology. 13, 4, p. 297-307  Abstract
154.
Huotari M., Miettinen P., Palgi J., Koivisto T., Ustinov J., Harari D., Yarden Y. & Otonkoski T. (2002) Endocrinology. 143, 11, p. 4437-4446  Abstract
153.
Katz M., Shtiegman K., Tal-Or P. et al. (2002) Traffic. 3, 10, p. 740-751  Abstract
[All authors]
152.
Citri A., Alroy I., Lavi S. et al. (2002) EMBO Journal. 21, 10, p. 2407-2417  Abstract
[All authors]
151.
Yarden Y. (2002) European Journal of Cancer. 38, p. S48-S48  Abstract
150.
Oved S. & Yarden Y. (2002) Nature. 416, 6877, p. 133-136  Abstract
149.
Waterman H., Katz M., Rubin C., Shtiegman K., Lavi S., Elson A., Jovin T. & Yarden Y. (2002) EMBO Journal. 21, 3, p. 303-313  Abstract
148.
The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities
Yarden Y. (2001) European Journal of Cancer. 37, p. S3-S8  Abstract
147.
Ettenberg S., Magnifico A., Cuello M., Nau M., Rubinstein Y., Yarden Y., Weissman A. & Lipkowitz S. (2001) Journal of Biological Chemistry. 276, 29, p. 27677-27684  Abstract
146.
Yarden Y. & Sliwkowski M. (2001) Nature Reviews Molecular Cell Biology. 2, 2, p. 127-137  Abstract
145.
Xu W., Mimnaugh E., Rosser M., Nicchitta C., Marcu M., Yarden Y. & Neckers L. (2001) Journal of Biological Chemistry. 276, 5, p. 3702-3708  Abstract
144.
Waterman H. & Yarden Y. (2001) FEBS Letters. 490, 3, p. 142-152  Abstract
143.
Bacus S., Gudkov A., Lowe M., Lyass L., Yung Y., Komarov A., Keyomarsi K., Yarden Y. & Seger R. (2001) Oncogene. 20, 2, p. 147-155  Abstract
142.
Yarden Y. (2001) Oncology. 61, p. 1-13  Abstract
141.
Rubin I. & Yarden Y. (2001) Annals of Oncology. 12, p. 3-8  Abstract
140.
Harari D. & Yarden Y. (2000) Oncogene. 19, 53, p. 6102-6114  Abstract
139.
Vaisman N., Nissim A., Klapper L., Tirosh B., Yarden Y. & Sela M. (2000) Immunology Letters. 75, 1, p. 61-67  Abstract
138.
Levkowitz G., Oved S., Klapper L., Harari D., Lavi S., Sela M. & Yarden Y. (2000) Journal of Biological Chemistry. 275, 45, p. 35532-35539  Abstract
137.
Bao J., Alroy I., Waterman H., Schejter E., Brodie C., Gruenberg J. & Yarden Y. (2000) Journal of Biological Chemistry. 275, 34, p. 26178-26186  Abstract
136.
Supino-Rosin L., Yoshimura A., Yarden Y., Elazar Z. & Neumann D. (2000) Journal of Biological Chemistry. 275, 29, p. 21850-21855  Abstract
135.
Hurwitz E., Klapper L., Wilchek M., Yarden Y. & Sela M. (2000) Cancer Immunology Immunotherapy. 49, 5-Apr, p. 226-234  Abstract
134.
Zhu Z., Kleeff J., Friess H., Wang L., Zimmermann A., Yarden Y., Buchler M. & Korc M. (2000) Biochemical and Biophysical Research Communications. 273, 3, p. 1019-1024  Abstract
133.
Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2
Klapper L., Waterman H., Sela M. & Yarden Y. (2000) Cancer Research. 60, 13, p. 3384-3388  Abstract
132.
Chausovsky A., Waterman H., Elbaum M., Yarden Y., Geiger B. & Bershadsky A. (2000) Oncogene. 19, 7, p. 878-888  Abstract
131.
Klapper L., Kirschbaum M., Sela M. & Yarden Y. (2000) Advances in Cancer Research. 77, p. 25-79  Abstract
130.
Lee R., Albanese C., Fu M. et al. (2000) Molecular and Cellular Biology. 20, 2, p. 672-683  Abstract [All authors]
129.
The ErbB/HER family of receptor tyrosine kinases: A potential target for chemoprevention of epithelial neoplasms
Kirschbaum M. & Yarden Y. (2000) Journal of Cellular Biochemistry. p. 52-60  Abstract
128.
Levkowitz G., Waterman H., Ettenberg S. et al. (1999) Molecular Cell. 4, 6, p. 1029-1040  Abstract [All authors]
127.
Yarden Y. (1999) European Journal of Cancer. 35, p. S133-S133  Abstract
126.
Waterman H., Levkowitz G., Alroy I. & Yarden Y. (1999) Journal of Biological Chemistry. 274, 32, p. 22151-22154  Abstract
125.
Soussan L., Burakov D., Daniels M., Toister-Achituv M., Porat A., Yarden Y. & Elazar Z. (1999) Journal of Cell Biology. 146, 2, p. 301-311  Abstract
124.
Brizzi M., Dentelli P., Rosso A., Yarden Y. & Pegoraro L. (1999) Journal of Biological Chemistry. 274, 24, p. 16965-16972  Abstract
123.
Waterman H., Alroy I., Strano S., Seger R. & Yarden Y. (1999) EMBO Journal. 18, 12, p. 3348-3358  Abstract
122.
Harari D., Tzahar E., Romano J., Shelly M., Pierce J., Andrews G. & Yarden Y. (1999) Oncogene. 18, 17, p. 2681-2689  Abstract
121.
Klapper L., Glathe S., Vaisman N., Hynes N., Andrews G., Sela M. & Yarden Y. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 9, p. 4995-5000  Abstract
120.
Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor
Alroy I., Soussan L., Seger R. & Yarden Y. (1999) Molecular and Cellular Biology. 19, 3, p. 1961-1972  Abstract
119.
Signal transduction by growth factors: Information transfer and processing by biological networks
Alroy I. & Yarden Y. (1999) Molecular Mechanisms Of Transcellular Signaling: From Membrane Receptors To Transcription Factors. 309, p. 142-166  Abstract
118.
Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W., Beguinot L., Geiger B. & Yarden Y. (1998) Genes & Development. 12, 23, p. 3663-3674  Abstract
117.
Morphogenetic effects of neuregulin (Neu differentiation factor) in cultured epithelial cells
Chausovsky A., Tsarfaty I., Kam Z., Yarden Y., Geiger B. & Bershadsky A. (1998) Molecular Biology of the Cell. 9, 11, p. 3195-3209  Abstract
116.
Tzahar E., Moyer J., Waterman H. et al. (1998) EMBO Journal. 17, 20, p. 5948-5963  Abstract
[All authors]
115.
ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network
Pinkas-Kramarski R., Shelly M., Guarino B. et al. (1998) Molecular and Cellular Biology. 18, 10, p. 6090-6101  Abstract [All authors]
113.
Lenferink A., Pinkas-Kramarski R., Van De Poll D. P. M. et al. (1998) EMBO Journal. 17, 12, p. 3385-3397  Abstract
[All authors]
112.
Waterman H., Sabanai I., Geiger B. & Yarden Y. (1998) Journal of Biological Chemistry. 273, 22, p. 13819-13827  Abstract
111.
Pinkas-Kramarski R., Lenferink A., Bacus S. et al. (1998) Oncogene. 16, 10, p. 1249-1258  Abstract [All authors]
110.
Eilam R., Pinkas-Kramarski R., Ratzkin B., Segal M. & Yarden Y. (1998) Proceedings of the National Academy of Sciences of the United States of America. 95, 4, p. 1888-1893  Abstract
109.
Tzahar E. & Yarden Y. (1998) Biochimica Et Biophysica Acta-Reviews On Cancer. 1377, 1, p. M25-M37  Abstract
108.
Zrihan-Licht S., Deng B., Yarden Y., Mcshan G., Keydar I. & Avraham H. (1998) Journal of Biological Chemistry. 273, 7, p. 4065-4072  Abstract
107.
Pinkaskramarski R., Eilam R., Alroy I., Levkowitz G., Lonai P. & Yarden Y. (1997) Oncogene. 15, 23, p. 2803-2815  Abstract
106.
Tzahar E., Pinkaskramarski R., Moyer J. et al. (1997) EMBO Journal. 16, 16, p. 4938-4950  Abstract
[All authors]
104.
Alroy I. & Yarden Y. (1997) FEBS Letters. 410, 1, p. 83-86  Abstract
103.
Klapper L., Vaisman N., Hurwitz E., Pinkaskramarski R., Yarden Y. & Sela M. (1997) Oncogene. 14, 17, p. 2099-2109  Abstract
102.
Pinkas-Kramarski R., Alroy I. & Yarden Y. (1997) Journal of Mammary Gland Biology and Neoplasia. 2, 2, p. 97-107  Abstract
101.
Goren D., Horowitz A., Zalipsky S., Woodle M., Yarden Y. & Gabizon A. (1996) British Journal of Cancer. 74, 11, p. 1749-1756  Abstract
100.
Tzahar E., Waterman H., Chen X., Levkowitz G., Karunagaran D., Lavi S., Ratzkin B. & Yarden Y. (1996) Molecular and Cellular Biology. 16, 10, p. 5276-5287  Abstract
99.
The gene encoding sarcoplasmic reticulum calcium ATPase-1 (Atp2a1) maps to distal mouse chromosome 7
Schleef M., Simonchazottes D., Lengeling A., Klocke R., Jockusch H., Yarden Y. & Guenet J. (1996) Mammalian Genome. 7, 10, p. 788-788  Abstract
98.
Kristt D. & Yarden Y. (1996) Cancer. 78, 6, p. 1272-1283  Abstract
97.
p91 STAT1 activation in interleukin-3-stimulated primary acute myeloid leukemia cells
Aronica M., Brizzi M., Dentelli P., Rosso A., Yarden Y. & Pegoraro L. (1996) Oncogene. 13, 5, p. 1017-1026  Abstract
96.
Neu differentiation factor neuregulin isoforms activate distinct receptor combinations
Pinkaskramarski R., Shelly M., Glathe S., Ratzkin B. & Yarden Y. (1996) Journal of Biological Chemistry. 271, 32, p. 19029-19032  Abstract
95.
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
Bacus S., Yarden Y., Oren M. et al. (1996) Oncogene. 12, 12, p. 2535-2547  Abstract
[All authors]
94.
Pinkaskramarski R., Soussan L., Waterman H. et al. (1996) EMBO Journal. 15, 10, p. 2452-2467  Abstract [All authors]
93.
Mincione G., Bianco C., Kannan S. et al. (1996) Journal of Cellular Biochemistry. 60, 4, p. 437-446  Abstract
[All authors]
92.
Chen X., Levkowitz G., Tzahar E. et al. (1996) Journal of Biological Chemistry. 271, 13, p. 7620-7629  Abstract
[All authors]
91.
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins
Levkowitz G., Klapper L., Tzahar E., Freywald A., Sela M. & Yarden Y. (1996) Oncogene. 12, 5, p. 1117-1125  Abstract
90.
Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93(fes), STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes
Brizzi M., Aronica M., Rosso A., Bagnara G., Yarden Y. & Pegoraro L. (1996) Journal of Biological Chemistry. 271, 7, p. 3562-3567  Abstract
89.
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors
Bacus S., Chin D., Yarden Y., Zelnick C. & Stern D. (1996) American Journal of Pathology. 148, 2, p. 549-558  Abstract
88.
Karunagaran D., Tzahar E., Beerli R., Chen X., Graus-Porta D., Ratzkin B., Seger R., Hynes N. & Yarden Y. (1996) EMBO Journal. 15, 2, p. 254-264  Abstract
87.
NEU DIFFERENTIATION FACTOR ACTIVATION OF ERBB-3 AND ERBB-4 IS CELL-SPECIFIC AND DISPLAYS A DIFFERENTIAL REQUIREMENT FOR ERBB-2
Beerli R., Grausporta D., Woodscook K., Chen X., Yarden Y. & Hynes N. (1995) Molecular and Cellular Biology. 15, 12, p. 6496-6505  Abstract
86.
Dong Z., Brennan A., Liu N., Yarden Y., Levkowitz G., Mirsky R. & Jessen K. (1995) Neuron. 15, 3, p. 585-596  Abstract
85.
ERBB-3 MEDIATES DIFFERENTIAL MITOGENIC EFFECTS OF NDF HEREGULIN ISOFORMS ON MOUSE KERATINOCYTES
Marikovsky M., Lavi S., Pinkaskramarski R., Karunagaran D., Liu N., Wen D. & Yarden Y. (1995) Oncogene. 10, 7, p. 1403-1411  Abstract
84.
Hurwitz E., Stancovski I., Sela M. & Yarden Y. (1995) Proceedings of the National Academy of Sciences of the United States of America. 92, 8, p. 3353-3357  Abstract
83.
NEU DIFFERENTIATION FACTOR INHIBITS EGF BINDING - A MODEL FOR TRANSREGULATION WITHIN THE ERBB FAMILY OF RECEPTOR TYROSINE KINASES
Karunagaran D., Tzahar E., Liu N., Wen D. & Yarden Y. (1995) Journal of Biological Chemistry. 270, 17, p. 9982-9990  Abstract
82.
ROLES FOR A CYTOPLASMIC TYROSINE AND TYROSINE KINASE-ACTIVITY IN THE INTERACTIONS OF NEU RECEPTORS WITH COATED PITS
Gilboa L., Benlevy R., Yarden Y. & Henis Y. (1995) Journal of Biological Chemistry. 270, 13, p. 7061-7067  Abstract
81.
STUDIES ON THE STRUCTURE AND FUNCTION OF GLYCOSYLATED AND NONGLYCOSYLATED NEU DIFFERENTIATION FACTORS - SIMILARITIES AND DIFFERENCES OF THE ALPHA-ISOFORM AND BETA-ISOFORM
Lu H., Chang D., Philo J. et al. (1995) Journal of Biological Chemistry. 270, 9, p. 4784-4791  Abstract
[All authors]
80.
Migdal M., Soker S., Yarden Y. & Neufeld G. (1995) Journal of Cellular Physiology. 162, 2, p. 266-276  Abstract
79.
Blechman J., Lev S., Barg J., Eisenstein M., Vaks B., Vogel Z., Givol D. & Yarden Y. (1995) Cell. 80, 1, p. 103-113  Abstract
78.
Marte B., Jeschke M., Grausporta D., Taverna D., Hofer P., Groner B., Yarden Y. & Hynes N. (1995) Molecular Endocrinology. 9, 1, p. 14-23  Abstract
77.
Blechman J. & Yarden Y. (1995) Receptor Activation by Antigens, Cytokines, Hormones, and Growth Factors. 766, p. 344-362  Abstract
76.
CONVERGENCE OF SIGNALING BY INTERLEUKIN-3, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND MAST-CELL GROWTH-FACTOR ON JAK2 TYROSINE KINASE
Brizzi M., Zini M., Aronica M., Blechman J., Yarden Y. & Pegoraro L. (1994) Journal of Biological Chemistry. 269, 50, p. 31680-31684  Abstract
75.
MEDULLARY CARCINOMA IS ASSOCIATED WITH EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 - IMPLICATION TO ITS MORPHOLOGY AND ITS CLINICAL BEHAVIOR
Bacus S., Zelnick C., Chin D., Yarden Y., Kaminsky D., Bennington J., Wen D., Marcus J. & Page D. (1994) American Journal of Pathology. 145, 6, p. 1337-1348  Abstract
74.
Tzahar E., Levkowitz G., Karunagaran D. et al. (1994) Journal of Biological Chemistry. 269, 40, p. 25226-25233  Abstract
[All authors]
73.
EXPRESSION OF THE ERBB-2 FAMILY OF GROWTH-FACTOR RECEPTORS AND THEIR LIGANDS IN BREAST CANCERS - IMPLICATION FOR TUMOR BIOLOGY AND CLINICAL BEHAVIOR
Bacus S., Zelnick C., Plowman G. & Yarden Y. (1994) American Journal of Clinical Pathology. 102, 4, p. S13-S24  Abstract
72.
Pinkaskramarski R., Eilam R., Spiegler O., Lavi S., Liu N., Chang D., Wen D., Schwartz M. & Yarden Y. (1994) Proceedings of the National Academy of Sciences of the United States of America. 91, 20, p. 9387-9391  Abstract
71.
Adelaide J., Penaultllorca F., Dib A., Yarden Y., Jacquemier J. & Birnbaum D. (1994) Genes Chromosomes & Cancer. 11, 1, p. 66-69  Abstract
70.
Ben-Levy R., Paterson H., Marshall C. & Yarden Y. (1994) EMBO Journal. 13, 14, p. 3302-3311  Abstract
69.
NEU DIFFERENTIATION FACTORS - A FAMILY OF ALTERNATIVELY SPLICED NEURONAL AND MESENCHYMAL FACTORS
Benbaruch N. & Yarden Y. (1994) Proceedings Of The Society For Experimental Biology And Medicine. 206, 3, p. 221-227  Abstract
68.
PROTEIN-KINASE C-DEPENDENT RELEASE OF A FUNCTIONAL WHOLE EXTRACELLULAR DOMAIN OF THE MAST-CELL GROWTH-FACTOR (MGF) RECEPTOR BY MGF-DEPENDENT HUMAN MYELOID CELLS
Brizzi M., Blechman J., Cavalloni G., Givol D., Yarden Y. & Pegoraro L. (1994) Oncogene. 9, 6, p. 1583-1589  Abstract
67.
Bartley T., Hunt R., Welcher A. et al. (1994) Nature. 368, 6471, p. 558-560  Abstract [All authors]
66.
STRUCTURAL AND FUNCTIONAL-ASPECTS OF THE MULTIPLICITY OF NEU DIFFERENTIATION FACTORS
Wen D., Suggs S., Karunagaran D. et al. (1994) Molecular and Cellular Biology. 14, 3, p. 1909-1919  Abstract
[All authors]
65.
Lev S., Blechman J., Givol D. & Yarden Y. (1994) Critical Reviews in Oncogenesis. 5, 3-Feb, p. 141-168  Abstract
64.
Stancovski I., Sela M. & Yarden Y. (1994) Mammary Tumorigenesis and Malignant Progression. Boston, MA: . Vol. 71. p. 161-191 (Cancer Treatment and Research).  Abstract
63.
TARGETING OF T-LYMPHOCYTES TO NEU/HER2-EXPRESSING CELLS USING CHIMERIC SINGLE-CHAIN FV RECEPTORS
Stancovski I., Schindler D., Waks T., Yarden Y., Sela M. & Eshhar Z. (1993) Journal of Immunology. 151, 11, p. 6577-6582  Abstract
62.
Peles E. & Yarden Y. (1993) BioEssays. 15, 12, p. 815-824  Abstract
61.
KIT-LIGAND (MAST-CELL GROWTH-FACTOR) INHIBITS THE GROWTH OF KIT-EXPRESSING MELANOMA-CELLS
Zakut R., Perlis R., Eliyahu S., Yarden Y., Givol D., Lyman S. & Halaban R. (1993) Oncogene. 8, 8, p. 2221-2229  Abstract
60.
RECEPTOR TYROSINE KINASE EXPRESSION IN ASTROCYTIC LESIONS - SIMILAR FEATURES IN GLIOSIS AND GLIOMA
Kristt D., Reedy E. & Yarden Y. (1993) Neurosurgery. 33, 1, p. 106-115  Abstract
59.
Blechman J., Lev S., Givol D. & Yarden Y. (1993) Stem Cells. 11, p. 12-21  Abstract
58.
EXPRESSION OF AMPHIREGULIN, CRIPTO-1, AND HEREGULIN-ALPHA IN HUMAN BREAST-CANCER CELLS
Normanno N., Qi C., Gullick W. et al. (1993) International Journal of Oncology. 2, 6, p. 903-911  Abstract [All authors]
57.
Halaban R., Tyrrell L., Longley J., Yarden Y. & Rubin J. (1993) Annals of the New York Academy of Sciences. 680, p. 290-301  Abstract
56.
Lev S., Blechman J., Nishikawa S., Givol D. & Yarden Y. (1993) Molecular and Cellular Biology. 13, 4, p. 2224-2234  Abstract
55.
Orrurtreger A., Trakhtenbrot L., Benlevy R., Wen D., Rechavi G., Lonai P. & Yarden Y. (1993) Proceedings of the National Academy of Sciences of the United States of America. 90, 5, p. 1867-1871  Abstract
54.
Peles E., Ben-Levy R., Tzahar E., Liu N., Wen D. & Yarden Y. (1993) EMBO Journal. 12, 3, p. 961-971  Abstract
53.
Blechman J., Lev S., Brizzi M., Leitner O., Pegoraro L., Givol D. & Yarden Y. (1993) Journal of Biological Chemistry. 268, 6, p. 4399-4406  Abstract
52.
Bacus S. S., Gudkov A. V., Zelnick C. R. et al. (1993) Cancer Research. 53, 21, p. 5251-5261  Abstract
[All authors]
51.
THE MURINE VIK GENE (CHROMOSOME-9) ENCODES A PUTATIVE RECEPTOR WITH UNIQUE PROTEIN-KINASE MOTIFS
Kelman Z., Simonchazottes D., Guenet J. & Yarden Y. (1993) Oncogene. 8, 1, p. 37-44  Abstract
50.
INSULIN AND INSULINOMIMETIC AGENTS INDUCE ACTIVATION OF PHOSPHATIDYLINOSITOL 3'-KINASE UPON ITS ASSOCIATION WITH PP185 (IRS-1) IN INTACT RAT LIVERS
Hadari Y., Tzahar E., Nadiv O., Rothenberg P., Roberts C., Leroith D., Yarden Y. & Zick Y. (1992) Journal of Biological Chemistry. 267, 25, p. 17483-17486  Abstract
49.
An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity
Ben-Levy R., Peles E., Goldman-Michael R. & Yarden Y. (1992) Journal of Biological Chemistry. 267, 24, p. 17304-17313  Abstract
48.
Lev S., Yarden Y. & Givol D. (1992) Journal of Biological Chemistry. 267, 22, p. 15970-15977  Abstract
47.
STRUCTURAL ORGANIZATION OF THE MURINE C-KIT PROTOONCOGENE
Gokkel E., Grossman Z., Ramot B., Yarden Y., Rechavi G. & Givoli D. (1992) Oncogene. 7, 7, p. 1423-1429  Abstract
46.
REGULATED COUPLING OF THE NEU RECEPTOR TO PHOSPHATIDYLINOSITOL 3'-KINASE AND ITS RELEASE BY ONCOGENIC ACTIVATION
Peles E., Lamprecht R., Benlevy R., Tzahar E. & Yarden Y. (1992) Journal of Biological Chemistry. 267, 17, p. 12266-12274  Abstract
45.
Hemmerich S., Yarden Y. & Pecht I. (1992) Biochemistry. 31, 19, p. 4574-4579  Abstract
44.
Wen D., Peles E., Cupples R. et al. (1992) Cell. 69, 3, p. 559-572  Abstract
[All authors]
43.
Yayon A., Zimmer Y., Shen G., Avivi A., Yarden Y. & Givol D. (1992) EMBO Journal. 11, 5, p. 1885-1890  Abstract
42.
Bacus S., Stancovski I., Huberman E., Chin D., Hurwitz E., Mills G., Ullrich A., Sela M. & Yarden Y. (1992) Cancer Research. 52, 9, p. 2580-2589  Abstract
41.
Lev S., Yarden Y. & Givol D. (1992) Journal of Biological Chemistry. 267, 15, p. 10866-10873  Abstract
40.
Peles E., Bacus S., Koski R., Lu H., Wen D., Ogden S., Benlevy R. & Yarden Y. (1992) Cell. 69, 1, p. 205-216  Abstract
39.
C-KIT-KINASE INDUCES A CASCADE OF PROTEIN TYROSINE PHOSPHORYLATION IN NORMAL HUMAN MELANOCYTES IN RESPONSE TO MAST-CELL GROWTH-FACTOR AND STIMULATES MITOGEN-ACTIVATED PROTEIN-KINASE BUT IS DOWN-REGULATED IN MELANOMAS
Funasaka Y., Boulton T., Cobb M. et al. (1992) Molecular Biology of the Cell. 3, 2, p. 197-209  Abstract
[All authors]
38.
Lev S., Givol D. & Yarden Y. (1992) Proceedings of the National Academy of Sciences of the United States of America. 89, 2, p. 678-682  Abstract
37.
Geiger B., Ayalon O., Ginsberg D., Volberg T., Fernandez J., Yarden Y. & Ben-Ze'Ev A. (1992) Cold Spring Harbor Symposia on Quantitative Biology. 57, p. 631-642  Abstract
36.
DEVELOPMENTAL EXPRESSION OF 2 MURINE FIBROBLAST GROWTH-FACTOR RECEPTORS, FLG AND BEK
Orrurtreger A., Givol D., Yayon A., Yarden Y. & Lonai P. (1991) Development. 113, 4, p. 1419-1434  Abstract
35.
Stancovski I., Hurwitz E., Leitner O., Ullrich A., Yarden Y. & Sela M. (1991) Proceedings of the National Academy of Sciences of the United States of America. 88, 19, p. 8691-8695  Abstract
34.
Peles E., Ben Levy R., Or E., Ullrich A. & Yarden Y. (1991) EMBO Journal. 10, 8, p. 2077-2086  Abstract
33.
FLG-2, A NEW MEMBER OF THE FAMILY OF FIBROBLAST GROWTH-FACTOR RECEPTORS
Avivi A., Zimmer Y., Yayon A., Yarden Y. & Givol D. (1991) Oncogene. 6, 6, p. 1089-1092  Abstract
32.
PCR-BASED IDENTIFICATION OF NEW RECEPTORS - MOLECULAR-CLONING OF A RECEPTOR FOR FIBROBLAST GROWTH-FACTORS
Raz V., Kelman Z., Avivi A., Neufeld G., Givol D. & Yarden Y. (1991) Oncogene. 6, 5, p. 753-760  Abstract
31.
Yarden Y. & Peles E. (1991) Biochemistry. 30, 14, p. 3543-3550  Abstract
30.
Lev S., Givol D. & Yarden Y. (1991) EMBO Journal. 10, 3, p. 647-654  Abstract
29.
A DOMINANT NEGATIVE MUTATION SUPPRESSES THE FUNCTION OF NORMAL EPIDERMAL GROWTH-FACTOR RECEPTORS BY HETERODIMERIZATION
Kashles O., Yarden Y., Fischer R., Ullrich A. & Schlessinger J. (1991) Molecular and Cellular Biology. 11, 3, p. 1454-1463  Abstract
28.
Yarden Y. (1990) Molecular Immunology. 27, 12, p. 1319-1324  Abstract
27.
Goldman R., Benlevy R., Peles E. & Yarden Y. (1990) Biochemistry. 29, 50, p. 11024-11028  Abstract
26.
Lev S., Yarden Y. & Givol D. (1990) Molecular and Cellular Biology. 10, 11, p. 6064-6068  Abstract
25.
DEVELOPMENTAL EXPRESSION OF C-KIT, A PROTOONCOGENE ENCODED BY THE W LOCUS
Orrurtreger A., Avivi A., Zimmer Y., Givol D., Yarden Y. & Lonai P. (1990) Development. 109, 4, p. 911-923  Abstract
24.
THE MURINE FLG GENE ENCODES A RECEPTOR FOR FIBROBLAST GROWTH-FACTOR
Safran A., Avivi A., Orrurtereger A., Neufeld G., Lonai P., Givol D. & Yarden Y. (1990) Oncogene. 5, 5, p. 635-643  Abstract
23.
Yarden Y. (1990) Proceedings of the National Academy of Sciences of the United States of America. 87, 7, p. 2569-2573  Abstract
22.
THE EPIDERMAL GROWTH-FACTOR RECEPTOR AS A SUBSTRATE FOR A KINASE-SPLITTING MEMBRANAL PROTEINASE
Seger R., Yarden Y., Kashles O., Goldblatt D., Schlessinger J. & Shaltiel S. (1988) Journal of Biological Chemistry. 263, 7, p. 3496-3500  Abstract
19.
Zidovetzki R., Yarden Y., Schlessinger J. & Jovin T. (1986) EMBO Journal. 5, 2, p. 247-250  Abstract
18.
Purification of an active EGF receptor kinase with monoclonal antireceptor antibodies
Yarden Y., Harari I. & Schlessinger J. (1985) Journal of Biological Chemistry. 260, 1, p. 315-319  Abstract
17.
Yarden Y. & Schlessinger J. (1985) Growth Factors in Biology and Medicine. p. 23-45  Abstract
16.
EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN-BRAIN TUMORS
Libermann T., Razon N., Bartal A., Yarden Y., Schlessinger J. & Soreq H. (1984) Cancer Research. 44, 2, p. 753-760  Abstract
15.
Ullrich A., Coussens L., Hayflick J. et al. (1984) Nature. 309, 5967, p. 418-425  Abstract [All authors]
14.
Lax I., Bareli M., Yarden Y., Libermann T. & Schlessinger J. (1984) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 81, 19, p. 5911-5915  Abstract
13.
Downward J., Yarden Y., Mayes E., Scrace G., Totty N., Stockwell P., Ullrich A., Schlessinger J. & Waterfield M. (1984) Nature. 307, 5951, p. 521-527  Abstract
12.
MONOCLONAL-ANTIBODY REACTIVE WITH THE HUMAN EPIDERMAL-GROWTH-FACTOR RECEPTOR RECOGNIZES THE BLOOD-GROUP-A ANTIGEN
Gooi H., Schlessinger J., Lax I., Yarden Y., Libermann T. & Feizi T. (1983) Bioscience Reports. 3, 11, p. 1045-1052  Abstract
11.
Yarden Y. & Schlessinger J. (1983) Cell Biology International Reports. 7, 7, p. 533-534  Abstract
10.
Hapgood J., Libermann T., Lax I., Yarden Y., Schreiber A., Naor Z. & Schlessinger J. (1983) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 80, 21, p. 6451-6455  Abstract
9.
Schlessinger J., Schreiber A., Levi A., Lax I., Libermann T. & Yarden Y. (1983) Crc Critical Reviews In Biochemistry. 14, 2, p. 93-111  Abstract
8.
POLYPEPTIDE-HORMONE-INDUCED RECEPTOR CLUSTERING AND INTERNALIZATION
Schlessinger J., Schreiber A., Libermann T., Lax I., Avivi A. & Yarden Y. (1983) Cell Membranes-Methods And Reviews. 1, p. 117-149  Abstract
7.
BIOLOGICAL ROLE OF EPIDERMAL GROWTH FACTOR-RECEPTOR CLUSTERING - INVESTIGATION WITH MONOCLONAL ANTI-RECEPTOR ANTIBODIES
Schreiber A., Libermann T., Lax I., Yarden Y. & Schlessinger J. (1983) Journal of Biological Chemistry. 258, 2, p. 846-853  Abstract
6.
EPIDERMAL GROWTH-FACTOR INDUCES ELECTRICALLY SILENT NA+ INFLUX IN HUMAN-FIBROBLASTS
Moolenaar W., Yarden Y., Delaat S. & Schlessinger J. (1982) Journal of Biological Chemistry. 257, 14, p. 8502-8506  Abstract
5.
Yarden Y., Schreiber A. & Schlessinger J. (1982) Journal of Cell Biology. 92, 3, p. 687-693  Abstract
4.
Schreiber A., Yarden Y. & Schlessinger J. (1981) Biochemical and Biophysical Research Communications. 101, 2, p. 517-523  Abstract
3.
Yarden Y., Gabbay M. & Schlessinger J. (1981) Biochimica Et Biophysica Acta. 674, 2, p. 188-203  Abstract
2.
Zidovetzki R., Yarden Y., Schlessinger J. & Jovin T. (1981) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 78, 11, p. 6981-6985  Abstract
1.
Schreiber A., Lax I., Yarden Y., Eshhar Z. & Schlessinger J. (1981) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 78, 12, p. 7535-7539  Abstract